Literature DB >> 27395418

Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.

Alessandro Prete1, Rosa Maria Paragliola1, Filomena Bottiglieri1, Carlo Antonio Rota1, Alfredo Pontecorvi1, Roberto Salvatori2, Salvatore Maria Corsello3.   

Abstract

Successful treatment of Cushing syndrome causes transient or permanent adrenal insufficiency deriving from endogenous hypercortisolism-induced hypothalamus-pituitary-adrenal-axis suppression. We analyzed pre-treatment factors potentially affecting the duration of adrenal insufficiency. We conducted a retrospective analysis on patients successfully treated for Cushing disease (15 patients) who underwent transsphenoidal surgery, and nonmalignant primary adrenal Cushing syndrome (31 patients) who underwent unilateral adrenalectomy, divided into patients with overt primary adrenal Cushing syndrome (14 patients) and subclinical primary adrenal Cushing syndrome (17 patients). Epidemiological data, medical history, and hormonal parameters depending on the etiology of hypercortisolism were collected and compared to the duration of adrenal insufficiency. The median duration of follow-up after surgery for Cushing disease and primary adrenal Cushing syndrome was 70 and 48 months, respectively. In the Cushing disease group, the median duration of adrenal insufficiency after transsphenoidal surgery was 15 months: younger age at diagnosis and longer duration of signs and symptoms of hypercortisolism before diagnosis and surgery were associated with longer duration of adrenal insufficiency. The median duration of adrenal insufficiency was 6 months for subclinical primary adrenal Cushing syndrome and 18.5 months for overt primary adrenal Cushing syndrome. The biochemical severity of hypercortisolism, the grade of hypothalamus-pituitary-adrenal-axis suppression, and treatment with ketoconazole before surgery accounted for longer duration of adrenal insufficiency. In patients with Cushing disease, younger age and delayed diagnosis and treatment predict longer need for glucocorticoid replacement therapy after successful transsphenoidal surgery. In patients with primary adrenal Cushing syndrome, the severity of hypercortisolism plays a primary role in influencing the duration of adrenal insufficiency after unilateral adrenalectomy.

Entities:  

Keywords:  Adrenal insufficiency; Adrenocortical adenoma; Cushing disease; Cushing syndrome

Mesh:

Year:  2016        PMID: 27395418     DOI: 10.1007/s12020-016-1007-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  33 in total

1.  Measurement of urinary free cortisol by current immunoassays: need for sex-dependent reference ranges to define hypercortisolism.

Authors:  T Deutschbein; M Broecker-Preuss; M F Hartmann; R Althoff; S A Wudy; K Mann; S Petersenn
Journal:  Horm Metab Res       Date:  2011-09-19       Impact factor: 2.936

2.  Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease.

Authors:  Felice Esposito; Joshua R Dusick; Pejman Cohan; Parham Moftakhar; David McArthur; Christina Wang; Ronald S Swerdloff; Daniel F Kelly
Journal:  J Clin Endocrinol Metab       Date:  2005-10-18       Impact factor: 5.958

3.  Nonconformity in the clinical practice guidelines for subclinical Cushing's syndrome: which guidelines are trustworthy?

Authors:  Jing Shen; Mingfang Sun; Bo Zhou; Juping Yan
Journal:  Eur J Endocrinol       Date:  2014-07-01       Impact factor: 6.664

4.  A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose.

Authors:  Silvia Persichilli; Jacopo Gervasoni; Federica Iavarone; Cecilia Zuppi
Journal:  Clin Chem Lab Med       Date:  2010-07-07       Impact factor: 3.694

5.  Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology.

Authors:  Christina M Berr; Guido Di Dalmazi; Andrea Osswald; Katrin Ritzel; Martin Bidlingmaier; Lucas L Geyer; Marcus Treitl; Klaus Hallfeldt; Walter Rachinger; Nicole Reisch; Rainer Blaser; Jochen Schopohl; Felix Beuschlein; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2014-12-29       Impact factor: 5.958

6.  Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma.

Authors:  Massimo Terzolo; Silvia Bovio; Anna Pia; Pier Antonio Conton; Giuseppe Reimondo; Chiara Dall'Asta; Donatella Bemporad; Alberto Angeli; Giuseppe Opocher; Massimo Mannelli; Bruno Ambrosi; Franco Mantero
Journal:  Eur J Endocrinol       Date:  2005-08       Impact factor: 6.664

7.  A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.

Authors:  J Newell-Price; P Trainer; L Perry; J Wass; A Grossman; M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1995-11       Impact factor: 3.478

Review 8.  Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: a systematic review of the literature.

Authors:  Guido Di Dalmazi; Christina M Berr; Martin Fassnacht; Felix Beuschlein; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2014-05-30       Impact factor: 5.958

Review 9.  Functional scintigraphy of the adrenal gland.

Authors:  Domenico Rubello; Chuong Bui; Dario Casara; Milton D Gross; Lorraine M Fig; Brahm Shapiro
Journal:  Eur J Endocrinol       Date:  2002-07       Impact factor: 6.664

10.  Common genetic variants in the glucocorticoid receptor and the 11β-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remission.

Authors:  Oskar Ragnarsson; Camilla A M Glad; Peter Berglund; Ragnhildur Bergthorsdottir; Derek N Eder; Gudmundur Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2014-06-10       Impact factor: 5.958

View more
  7 in total

Review 1.  Current best practice in the management of patients after pituitary surgery.

Authors:  Alessandro Prete; Salvatore Maria Corsello; Roberto Salvatori
Journal:  Ther Adv Endocrinol Metab       Date:  2017-03-01       Impact factor: 3.565

2.  Factors predicting prolonged glucocorticoid therapy in patients with adrenal insufficiency after laparoscopic adrenalectomy.

Authors:  Francesco Ziglioli; Simona Cataldo; Domenico Maria Cavalieri; Davide Campobasso; Umberto Maestroni
Journal:  Ann Med Surg (Lond)       Date:  2022-03-10

3.  The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers.

Authors:  Shobana Athimulam; Danae Delivanis; Melinda Thomas; William F Young; Sundeep Khosla; Matthew T Drake; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

4.  Predictability of hypoadrenalism occurrence and duration after adrenalectomy for ACTH-independent hypercortisolism.

Authors:  V Morelli; L Minelli; C Eller-Vainicher; S Palmieri; E Cairoli; A Spada; M Arosio; I Chiodini
Journal:  J Endocrinol Invest       Date:  2017-11-18       Impact factor: 4.256

Review 5.  Adrenalectomy for Cushing's syndrome: do's and don'ts.

Authors:  D N Paduraru; A Nica; M Carsote; A Valea
Journal:  J Med Life       Date:  2016 Oct-Dec

6.  A New Insight into the Surgical Treatment of Primary Macronodular Adrenal Hyperplasia.

Authors:  Fabio Yoshiaki Tanno; Victor Srougi; Madson Q Almeida; Fernando Ide Yamauchi; Fernando Morbeck Almeida Coelho; Mirian Yumie Nishi; Maria Claudia Nogueira Zerbini; Iracy Silvia Correa Soares; Maria Adelaide Albergaria Pereira; Helaine Laiz Silva Charchar; Amanda Meneses Ferreira Lacombe; Vania Balderrama Brondani; Miguel Srougi; Willian Carlos Nahas; Berenice B Mendonca; José Luis Chambô; Maria Candida Barisson Villares Fragoso
Journal:  J Endocr Soc       Date:  2020-07-22

Review 7.  Approach to the Patient With Adrenal Incidentaloma.

Authors:  Irina Bancos; Alessandro Prete
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.